Your browser doesn't support javascript.
loading
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Lee, Nancy Y; Ferris, Robert L; Psyrri, Amanda; Haddad, Robert I; Tahara, Makoto; Bourhis, Jean; Harrington, Kevin; Chang, Peter Mu-Hsin; Lin, Jin-Ching; Razaq, Mohammad Abdul; Teixeira, Maria Margarida; Lövey, József; Chamois, Jerome; Rueda, Antonio; Hu, Chaosu; Dunn, Lara A; Dvorkin, Mikhail Vladimirovich; De Beukelaer, Steven; Pavlov, Dmitri; Thurm, Holger; Cohen, Ezra.
  • Lee NY; Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: leen2@mskcc.org.
  • Ferris RL; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Psyrri A; Attikon University Hospital, National Kapodistrian University of Athens, Athens, Greece.
  • Haddad RI; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Tahara M; National Cancer Center Hospital East, Kashiwa, Japan.
  • Bourhis J; Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland.
  • Harrington K; The Royal Marsden Hospital-The Institute of Cancer Research National Institute for Health Research Biomedical Research Centre, London, UK.
  • Chang PM; Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan.
  • Lin JC; Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan.
  • Razaq MA; Stephenson Cancer Center, University of Oklahoma, Oklahoma, OK, USA.
  • Teixeira MM; Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE, Coimbra, Portugal.
  • Lövey J; Országos Onkológiai Intézet, Sugárterápiás Osztály Semmelweis Egyetem, Onkológiai Tanszék, Budapest, Hungary.
  • Chamois J; Centre Hospitalier Prive Saint Gregoire, Saint Gregoire, France.
  • Rueda A; Medical Oncology, Costa del Sol Sanitary Agency and Regional University Hospital, IBIMA, Málaga, Spain.
  • Hu C; Fudan University Cancer Hospital, Xuhui, Shanghai, China.
  • Dunn LA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dvorkin MV; Budgetary Institution of Healthcare of the Omsk Region, Clinical Oncology Dispensary, Omsk, Russia.
  • De Beukelaer S; Pfizer, Zürich, Switzerland.
  • Pavlov D; Pfizer, La Jolla, CA, USA.
  • Thurm H; Pfizer, La Jolla, CA, USA.
  • Cohen E; Moores Cancer Center, UC San Diego Health, La Jolla, CA, USA.
Lancet Oncol ; 22(4): 450-462, 2021 04.
Article en En | MEDLINE | ID: mdl-33794205
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anticuerpos Monoclonales Humanizados / Carcinoma de Células Escamosas de Cabeza y Cuello / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anticuerpos Monoclonales Humanizados / Carcinoma de Células Escamosas de Cabeza y Cuello / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article